{
    "eid": "2-s2.0-84928780036",
    "title": "Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research",
    "cover-date": "2016-07-01",
    "subject-areas": [
        {
            "$": "Neurology",
            "@code": "2808"
        },
        {
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804"
        },
        {
            "$": "Neuroscience (miscellaneous)",
            "@code": "2801"
        }
    ],
    "keywords": [
        "Depression",
        "IDO",
        "Immune",
        "Inflammation",
        "Leaky gut",
        "Neuroprogression",
        "Oxidative and nitrosative stress",
        "TRYCATs"
    ],
    "authors": [
        "Michael Maes"
    ],
    "citedby-count": 34,
    "ref-count": 90,
    "ref-list": [
        "Antidepressants and the placebo response",
        "So depression is an inflammatory disease, but where does the inflammation come from?",
        "Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: A systematic qualitative review",
        "Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects a systematic review and meta-analysis of randomized clinical trials",
        "Depression\u2010related disturbances in mitogen\u2010induced lymphocyte responses and interleukin\u20101\u03b2 and soluble interleukin\u20102 receptor production",
        "Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls",
        "New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors",
        "Immune disturbances during major depression: Upregulated expression of interleukin-2 receptors",
        "Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients",
        "Lowered \u03c93 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients",
        "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness",
        "Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness",
        "IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology",
        "The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression.",
        "Role of the toll like receptor (TLR) radical cycle in chronic inflammation: Possible treatments targeting the TLR4 pathway",
        "Toll-like receptor 4: Innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder",
        "Association between toll-like receptors expression and major depressive disorder",
        "Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder",
        "Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression",
        "Psychological and behavioural effects of interferons",
        "The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression",
        "Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: Relationship with immune-inflammatory markers",
        "Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression",
        "In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression",
        "A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4months",
        "Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression",
        "Stress-induced neuroinflammation: Role of the toll-like receptor-4 pathway",
        "The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression",
        "Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors",
        "The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications",
        "Inflammatory and neurodegenerative pathways in depression: A new avenue for antidepressant development?",
        "The monocyte-T-lymphocyte hypothesis of major depression",
        "Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways",
        "Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings",
        "Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men",
        "The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease",
        "Haptoglobin: Old protein with new functions",
        "Haptoglobin, inflammation and disease",
        "Il-6 trans-signaling via the soluble IL-6 receptor: Importance for the proinflammatory activities of IL-6",
        "Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression",
        "Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?",
        "Human disease classification in the postgenomic era: A complex systems approach to human pathobiology",
        "Monoaminergic neurotransmission: The history of the discovery of antidepressants from 1950s until today",
        "Active placebos versus antidepressants for depression",
        "Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan",
        "Interleukin\u20106 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine",
        "Tricyclic antidepressants inhibit IL-6, IL-1\u03b2 and TNF-\u03b1 release in human blood monocytes and IL-2 and interferon-\u03b3 in T cells",
        "Negative immunoregulatory effects of antidepressants inhibition of interferon-\u03b3 and stimulation of interleukin-10 secretion",
        "Effects of antidepressants on the production of cytokines",
        "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: A meta-analysis",
        "Impact of antidepressants on cytokine production of depressed patients in vitro.",
        "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways",
        "The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): Relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation",
        "The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "Nitrosothiols in the immune system: Signaling and protection",
        "Oxidative & nitrosative stress in depression: Why so much stress?",
        "Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-\u03b3 activation after stress in rats",
        "Stress as a neuroinflammatory condition in brain: Damaging and protective mechanisms",
        "Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats",
        "Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression",
        "The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder",
        "Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: Randomized double-blind placebo-controlled trial",
        "The impact of statins on psychological wellbeing: 12A systematic review and meta-analysis",
        "Clinical implications of the cytokine hypothesis of depression: The association between use of statins and aspirin and the risk of major depression",
        "The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: Proof of concept for the inflammatory and oxidative hypotheses of depression?",
        "Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial",
        "J Neurol Sci 2014; Available online",
        "Neuropsychiatric adverse events associated with statins: Epidemiology, pathophysiology, prevention and management",
        "Statin-associated necrotizing autoimmune myopathy",
        "A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers",
        "Handbook of Systemic Autoimmune Diseases, volume 6",
        "Prevalence and management of panic attacks during infliximab infusion in psoriatic patients",
        "Suicide attempt in ulcerative colitis patient after 4months of infliximab therapy - A case report",
        "Induction of manic switch by the tumour necrosis factor-\u03b1 antagonist infliximab",
        "Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor \u03b1: Findings in open-label and randomized placebo-controlled trials",
        "Putative neuroprotective agents in neuropsychiatric disorders",
        "The efficacy of zinc supplementation in depression: Systematic review of randomised controlled trials",
        "N-acetylcysteine for major depressive episodes in bipolar disorder",
        "Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Krakow",
            "affilname": "Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Zhanjiang",
            "affilname": "Guangdong Ocean University",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Esch-sur-Alzette",
            "affilname": "University of Luxembourg",
            "affiliation-country": "Luxembourg"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "affilname": "Universidade Estadual de Londrina",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Madrid",
            "affilname": "Universidad Complutense de Madrid",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "University of Melbourne",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Krakow",
            "affilname": "Jagiellonian University Medical College",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Halifax",
            "affilname": "Dalhousie University",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Groningen",
            "affilname": "Rijksuniversiteit Groningen",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Lodz",
            "affilname": "Medical University of Lodz",
            "affiliation-country": "Poland"
        }
    ],
    "funding": [
        "National Health and Medical Research Council",
        "National Health and Medical Research Council"
    ]
}